Pneumococcal conjugate second or third-dose vaccines (PCVc) in Pakistan
Pakistan: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 86.0% in 2025. ◆ Volatile
Latest (2025)
86.0%
Change on year
down 1.1%
World rank
92nd
of 194 countries
All-time high
87.0%
in 2024
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Pakistan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Pakistan is 86.0%, measured in 2025.
That represents a change of down 1.1% on the previous year and up 7.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Pakistan peaked at 87.0% in 2024 and was at its lowest, 0.0%, in 2008.
Pakistan ranks 92nd of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Pakistan, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 65.0% | — |
| 2014 | 68.0% | +4.6% |
| 2015 | 80.0% | +17.6% |
| 2016 | 78.0% | -2.5% |
| 2017 | 82.0% | +5.1% |
| 2018 | 82.0% | +0.0% |
| 2019 | 83.0% | +1.2% |
| 2020 | 82.0% | -1.2% |
| 2021 | 83.0% | +1.2% |
| 2022 | 85.0% | +2.4% |
| 2023 | 86.0% | +1.2% |
| 2024 | 87.0% | +1.2% |
| 2025 | 86.0% | -1.1% |
Pakistan compared with similar countries
- Pakistan's 86.0% is above the median for lower middle income countries, which is 84.0%, 1.0× the median. (47 countries reporting)
- Pakistan's 86.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 91.0%, 95% of the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 53.8% | 0.0% | 83.0% | 10 |
| 2020s | 84.8% | 82.0% | 87.0% | 6 |
Countries ranked near Pakistan
More health data for Pakistan
- Un projection of annual infant deaths, annual growth rate -2.14 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8219 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 944.5 deaths per 1,000 people (2090)
- Number of infants who die before age 1 55,286 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 335 (2025)
- Population ages 00-04, female, annual growth rate 0.5028 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0616 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4109 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Pakistan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Pakistan was 86.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Pakistan?
- The highest recorded value was 87.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Pakistan?
- The lowest recorded value was 0.0% in 2008.
- How does Pakistan rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Pakistan ranks 92nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Pakistan?
- Over the last ten years it is up 7.5%. The long-run trend across the full record is volatile.
- Where does this Pakistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).